Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12


Novel prokaryotic expression of thioredoxin-fused insulinoma associated protein tyrosine phosphatase 2 (IA-2), its characterization and immunodiagnostic application.

Guerra LL, Faccinetti NI, Trabucchi A, Rovitto BD, Sabljic AV, Poskus E, Iacono RF, Valdez SN.

BMC Biotechnol. 2016 Nov 24;16(1):84.


Anti-Insulin Immune Responses Are Detectable in Dogs with Spontaneous Diabetes.

Kim JH, Furrow E, Ritt MG, Utz PJ, Robinson WH, Yu L, Eckert A, Stuebner K, O'Brien TD, Steinman L, Modiano JF.

PLoS One. 2016 Mar 31;11(3):e0152397. doi: 10.1371/journal.pone.0152397. eCollection 2016 Mar 31.


New directions for research into type 1 diabetes in India--an immunological perspective.

Unnikrishnan R, Mohan V.

Indian J Med Res. 2014 Sep;140(3):336-8. No abstract available.


CD226 rs763361 is associated with the susceptibility to type 1 diabetes and greater frequency of GAD65 autoantibody in a Brazilian cohort.

Mattana TC, Santos AS, Fukui RT, Mainardi-Novo DT, Costa VS, Santos RF, Matioli SR, da Silva ME.

Mediators Inflamm. 2014;2014:694948. doi: 10.1155/2014/694948. Epub 2014 May 7.


Autoimmunity against INS-IGF2 protein expressed in human pancreatic islets.

Kanatsuna N, Taneera J, Vaziri-Sani F, Wierup N, Larsson HE, Delli A, Skärstrand H, Balhuizen A, Bennet H, Steiner DF, Törn C, Fex M, Lernmark Å.

J Biol Chem. 2013 Oct 4;288(40):29013-23. doi: 10.1074/jbc.M113.478222. Epub 2013 Aug 9.


Zinc transporter 8 autoantibodies and their association with SLC30A8 and HLA-DQ genes differ between immigrant and Swedish patients with newly diagnosed type 1 diabetes in the Better Diabetes Diagnosis study.

Delli AJ, Vaziri-Sani F, Lindblad B, Elding-Larsson H, Carlsson A, Forsander G, Ivarsson SA, Ludvigsson J, Kockum I, Marcus C, Samuelsson U, Örtqvist E, Groop L, Bondinas GP, Papadopoulos GK, Lernmark Å; Better Diabetes Diagnosis Study Group..

Diabetes. 2012 Oct;61(10):2556-64. Epub 2012 Jul 10.


Dysregulated Toll-like receptor-induced interleukin-1β and interleukin-6 responses in subjects at risk for the development of type 1 diabetes.

Alkanani AK, Rewers M, Dong F, Waugh K, Gottlieb PA, Zipris D.

Diabetes. 2012 Oct;61(10):2525-33. Epub 2012 Jun 29.


Etiopathogenesis of insulin autoimmunity.

Kanatsuna N, Papadopoulos GK, Moustakas AK, Lenmark A.

Anat Res Int. 2012;2012:457546. doi: 10.1155/2012/457546. Epub 2012 Feb 22.


2α-Methyl-19-nor-(20S)-1,25-dihydroxyvitamin D(3) protects the insulin 2 knockout non-obese diabetic mouse from developing type 1 diabetes without hypercalcaemia.

Kiekhaefer CM, Weber B, Huggins M, Gorichanaz C, Nehring JA, DeLuca HF.

Clin Exp Immunol. 2011 Dec;166(3):325-32. doi: 10.1111/j.1365-2249.2011.04481.x.


Attacking the source: anti-PDX-1 responses in type 1 diabetes.

Luzardo Y, Mathews CE.

Lab Invest. 2010 Jan;90(1):6-8. doi: 10.1038/labinvest.2009.121.


Insulin receptor substrate-2 in beta-cells decreases diabetes in nonobese diabetic mice.

Norquay LD, D'Aquino KE, Opare-Addo LM, Kuznetsova A, Haas M, Bluestone JA, White MF.

Endocrinology. 2009 Oct;150(10):4531-40. doi: 10.1210/en.2009-0395. Epub 2009 Jul 2.

Supplemental Content

Support Center